The medical profession enjoys lots of respect from the public. People literally trust their doctors and surgeons with their lives. They take their advice about treatment options seriously, because they believe in the medical profession and the wisdom of the FDA.
This explicit trust is one reason it feels like such a violation when defective drugs and medical devices are exposed. Patients in Indiana should be aware of product recalls and new research showing that some drugs and devices are unsafe for users.
One recent example of this is the case of Elmiron. Elmiron is most often prescribed for interstitial cystitis, a condition that causes pain in the bladder. However, recently Elmiron has been shown to cause eye trouble up to and including blindness. Elmiron has been on the market in the United States since 1996. The FDA approved this drug after extensive trials. During that time, no side effects related to eyesight were observed.
Elmiron is made by Janssen Pharmaceuticals. Right now people are starting to question how much Janssen knew about the side effects. Some experts have begun to suspect that Janssen Pharmaceuticals knew of the risks and kept information about them from the public. Luckily, there’s a solution for situations like this. Attorneys in states like Pennsylvania are beginning to seek redress for patients who have experienced these side effects.
Because of Janssen’s negligence in not sounding the alarm to doctors and patients, people have suffered serious changes to their vision. Janssen has a duty of care to patients who’ve put their trust in the drug. Macular degeneration, maculopathy and eye damage are too high a price to pay for using this drug.